Skip to main content
Martin McCarter, MD, General Surgery, Aurora, CO

MartinMcCarterMD

General Surgery Aurora, CO

Melanoma, Surgical Oncology (Other than Breast), Minimally Invasive Surgery

Professor of Surgery, University Colorado

Overview of Dr. McCarter

Dr. Martin McCarter is a general surgeon in Aurora, CO and is affiliated with University of Colorado Hospital. He received his medical degree from University of Vermont College of Medicine and has been in practice 25 years. Dr. McCarter accepts several types of health insurance, listed below. He is one of 199 doctors at University of Colorado Hospital who specialize in General Surgery. He has more than 100 publications and over 500 citings.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 1999 - 2001
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 1992 - 1999
  • University of Vermont College of Medicine
    University of Vermont College of MedicineClass of 1992
  • Dartmouth College
    Dartmouth CollegeA.B., Biology, 1987

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2001 - 2025
  • NY State Medical License
    NY State Medical License 1993 - 2002
  • American Board of Surgery Surgery

Awards, Honors, & Recognition

  • Norman E. Shumway Award for Best Podium Presentation Western Thoracic Surgery Association, 2016
  • Best Doctors in America 2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • BRAF Fusions Identified in Melanomas Have Variable Treatment Responses and Phenotypes  
    Hannah Lee, William A Robinson, Martin McCarter, Nature
  • Soft Tissue Sarcoma, Version 22018, NCCN Clinical Practice Guidelines in Oncology  
    von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM 3rd, Keedy V, Kim E, Koon H, Mayerson J, McCarter M, McGar..., J Natl Compr Canc Netw, 1/1/2018
  • Recurrent solid pseudopapillary neoplasm of pancreas: Case report and review of literature  
    Sharma PK, Mehrotra S, Gleisner AL, Schulick RD, McCarter MD, Journal of Pancreatic Cancer, 1/1/2018
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Immune studies in esophageal cancer.
    McCarter MD, Paul O�Hara II Esophagogastric Cancer Symposium, Aurora, CO, 1/25/2018
  • Influence of Age and Gender on Tumor Site and Disease Free Survival in Head and Neck Melanoma.
    Torphy R, Friedman C, Trihn B, Chapman C, Gleisner A, McCarter M, Robinson W, Kounalakis N, Society for Surgical Oncology, Chicago, IL, 1/23/2018
  • Quality of Life Following Major Laparoscopic or Open Pancreatic Resection.
    Torphy R, Chapman B, Friedman C, Paniccia A, Meguid C, Bartsch C, McCarter M, Schulick R, Edil B, Gleisner A, Society For Surgical Oncology, Chicago, IL, 1/22/2018
  • Join now to see all

Other

  • Advances in the surveillance and treatment of Barrett esophagus. 
    McCarter MD, Audio-Digest General Surgery
    1/21/2015
  • Minimally invasive esophagectomy: Is it worth the effort? 
    McCarter MD, Audio-Digest General Surgery
    1/21/2015
  • De-Mystifying Clinical Trials 
    McCarter MD, Debbie�s Dream Foundation Webinar
    http://www.debbiesdream.org/portal/lecture-library
    1/6/2015
  • Join now to see all

Authored Content

  • Utility of Viscoelastic Assays Beyond Coagulation: Can Preoperative Thrombelastography Indices Predict Tumor Histology, Nodal Disease, and Resectability in Patients Undergoing Pancreatectomy?March 2018

Press Mentions

  • Melanoma Clinical Trial Reveals Success of Drug Combination
    Melanoma Clinical Trial Reveals Success of Drug CombinationDecember 8th, 2022
  • Iovance Biotherapeutics Announces Updated Clinical Data for Lifileucel in Advanced Melanoma at Society for Immunotherapy of Cancer (SITC) Annual Meeting
    Iovance Biotherapeutics Announces Updated Clinical Data for Lifileucel in Advanced Melanoma at Society for Immunotherapy of Cancer (SITC) Annual MeetingNovember 10th, 2022
  • Increase in Cancer Deaths Predicted Due to COVID-19 Pandemic
    Increase in Cancer Deaths Predicted Due to COVID-19 PandemicDecember 22nd, 2020
  • Join now to see all

Professional Memberships

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    Anthem PPO
    BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Cofinity PPO
    First Health PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Kaiser Permanente
    Multiplan PPO
    Rocky Mountain Group/Indiv - HMO/Private Pay
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment